NOMIFENSINE - EFFECT IN PARKINSONIAN-PATIENTS NOT RECEIVING LEVODOPA

被引：21

作者：

PARK, DM ^{[1
]}

FINDLEY, LJ ^{[1
]}

HANKS, G ^{[1
]}

SANDLER, M ^{[1
]}

机构：

[1] CHARING CROSS HOSP,DEPT NEUROL,LONDON W6 8RF,ENGLAND

来源：

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY | 1981年 / 44卷 / 04期

关键词：

D O I：

10.1136/jnnp.44.4.352

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：352 / 354

页数：3

共 50 条

[1] PHARMACODYNAMICS OF THE HYPOTENSIVE EFFECT OF LEVODOPA IN PARKINSONIAN-PATIENTS
IRWIN, RP
NUTT, JG
WOODWARD, WR
GANCHER, ST
CLINICAL NEUROPHARMACOLOGY, 1992, 15 (05) : 365 - 374
[2] LEVODOPA PHARMACOKINETICS AND PHARMACODYNAMICS IN FLUCTUATING PARKINSONIAN-PATIENTS
NUTT, JG
WOODWARD, WR
NEUROLOGY, 1986, 36 (06) : 739 - 744
[3] THE EFFECT OF LEVODOPA TREATMENT ON THE VISUAL EVOKED-POTENTIALS IN PARKINSONIAN-PATIENTS
YAAR, I
ELECTROENCEPHALOGRAPHY AND CLINICAL NEUROPHYSIOLOGY, 1980, 50 (3-4): : 267 - 274
[4] RELEVANCE OF PHARMACOKINETIC HANDLING TO TERMINATION OF EFFECT OF LEVODOPA IN ELDERLY PARKINSONIAN-PATIENTS
BOWES, SG
ONEILL, CJA
DESHMUKH, AA
LEEMAN, AL
DOBBS, SM
DOBBS, RJ
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1989, 27 (01) : P123 - P124
[5] CELL-MEDIATED-IMMUNITY TO LEVODOPA IN PARKINSONIAN-PATIENTS
KURITZKY, A
DAVIDOVITCH, S
LIVNI, E
BECHAR, M
ISRAEL JOURNAL OF MEDICAL SCIENCES, 1979, 15 (03): : 293 - 294
[6] NOCTURNAL MYOCLONUS IN PARKINSONIAN-PATIENTS UNDER LEVODOPA AND BROMOCRIPTINE
VARDI, J
GLOBMAN, H
RABEY, JM
STREIFLER, M
ISRAEL JOURNAL OF MEDICAL SCIENCES, 1979, 15 (03): : 293 - 293
[7] LONG-TERM FOLLOW-UP ON PARKINSONIAN-PATIENTS RECEIVING EARLY LEVODOPA TREATMENT
MARKHAM, CH
DIAMOND, SG
ANNALS OF NEUROLOGY, 1985, 18 (01) : 116 - 117
[8] EFFECT OF ENTACAPONE, A COMT INHIBITOR, ON CLINICAL DISABILITY AND LEVODOPA METABOLISM IN PARKINSONIAN-PATIENTS
KAAKKOLA, S
TERAVAINEN, H
AHTILA, S
RITA, H
GORDIN, A
NEUROLOGY, 1994, 44 (01) : 77 - 80
[9] PLASMA LEVODOPA, DOPAMINE AND THERAPEUTIC RESPONSE FOLLOWING LEVODOPA THERAPY OF PARKINSONIAN-PATIENTS
ROSSOR, MN
WATKINS, J
BROWN, MJ
REID, JL
DOLLERY, CT
JOURNAL OF THE NEUROLOGICAL SCIENCES, 1980, 46 (03) : 385 - 392
[10] INCREASED DOSAGE OF CARBIDOPA IN PARKINSONIAN-PATIENTS ON LOW CARBIDOPA-LEVODOPA REGIMEN - EFFECT ON LEVODOPA BIOAVAILABILITY
CONTIN, M
RIVA, R
MARTINELLI, P
PROCACCIANTI, G
BARUZZI, A
CLINICAL NEUROPHARMACOLOGY, 1989, 12 (01) : 75 - 81

← 1 2 3 4 5 →